9th Annual Biomarkers Congress

Cancer Biology: The Mayo Clinic

Total Score People Score Events Score
84 65 47
Date Event Presentation Speakers
March 5, 2014 Targeted Anticancer Therapies Miscellaneous Drug Targets and Their Inhibitors/Modulators Gary Schwartz
April 6, 2013 AACR Annual Meetings Targeting Lymphoid Malignancies: Working from the Outside In Co-Chairpersons: John P. Leonard, Weill Cornell Medical Center, New York, NY, and John C. Byrd, The Ohio State University Comprehensive Cancer Center, Columbus, OH James R. Cerhan
Endocrine Resistance in Breast Cancer Chairperson: Nancy E. Davidson, University of Pittsburgh Cancer Institute, Pittsburgh, PA Matthew P . Goetz
DNA Damage Response: What Do We Know Now and What Will We Learn Next? Chairperson: Junjie Chen, The University of Texas MD Anderson Cancer Center, Houston, TX Junjie Chen
Genetic Epidemiology of Pancreatic Cancer Gloria M. Petersen, Mayo Clinic College of Medicine, Rochester, MN Gloria M. Petersen
January 31, 2013 5th Immunotherapeutics & Immunomonitoring The Immune System in Breast Cancer Initiation and Progression: Role of Epithelial to Mesenchymal Transition Keith Knutson
December 4, 2012 CTRC-AACR San Antonio Breast Cancer Symposium Mini-Symposium 2 - Exhibit Hall D Breast Density: Mechanisms and Clinical Implications Celine M. Vachon
October 4, 2012 14th Annual Lynn Sage Breast Cancer Symposium Session 1 | Supportive Oncology Lynn C Hartmann
Benign Breast Disease and Risk: What’s New? Lynn C Hartmann
September 13, 2012 International Society of Gastrointestinal Oncology Bevacizumab Axel Grothey
Screening for Colorectal Cancer with Emphasis on Stool DNA David A. Ahlquist
Session 5 | Localized/Adjuvant Colorectal Cancer Axel Grothey
Case 1: Elderly Patient with Stage III Colon Cancer Joleen M. Hubbard
Laparoscopic Surgery of Rectal Cancer: Are We There Yet? Heidi Nelson
Molecular Markers, Molecular Signatures and Treatment Decision in Stage II Colon Cancer Daniel J. Sargent
May 3, 2012 Thrombosis and Hemostasis Summit of North America (THSNA) 3. Lab Monitoring of Anticoagulation Rajiv K. Pruthi
Predicting the Risk of VTE Recurrence John A. Heit
2. Inherited Coagulopathies Rajiv K. Pruthi
November 12, 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Concurrent Session 8 | Targeting the androgen receptor in castration-resistant prostate cancer Donald J Tindall
November 11, 2011 IBD 2011: Progress and Future for Lifelong Management Session V Current therapeutic strategy depend on the treatment guidelines in USA, EU, Asia and Japan Edward V. Loftus
August 31, 2011 Strategies for Engineered Negligible Senescence, 5th Conference (SENS5) Repolulation of intestinal crypts by circulating EPCs Graca Almeida-Porada
Contribution to aging of senescent cells in adipose tissue Lori Kirkland
June 30, 2011 2011 AHPBA Americas Post Graduate Course Session 5 | Minimally Invasive Techniques in Hepatobiliary Surgery | North and South Horacio Asbun
Session 6 | Interesting Case/Video Presentation Competition and Case Studies I-VI Horacio Asbun
June 19, 2011 7th ISABS Conference on Forensic Genetics and Molecular Medicine Molecular Medicine 1 | Clinical genetics in individualized medicine Dusica Babovic-Vuksanovic
Biomathematical Modeling and Cancer Immunotherapy 2 | Impairment of cellular immunity in human cancer Stanimir Vuk-Pavlovic
Cell Therapy | Stem cell platforms for heart repair Andre Terzic
Cell Therapy | Introduction from the chair Andre Terzic
NextGen Sequencing | Clinical NextGen Sequencing of hereditary colon cancer genes Matthew Ferber
NextGen Sequencing | Molecularly defined cancer subtypes using NextGen Sequencing George Vasmatzis
NextGen Sequencing | Integration of multiple data types obtained from genomics experiments: challenges and opportunities Jean-Pierre Kocher
NextGen Sequencing | Next Generation Sequencing of oropharingeal cancers David I. Smith
NextGen Sequencing | The Next Generation Sequencing Revolution David I. Smith
Molecular Medicine 2 | Prediction of pathophenotype through transcriptome deconvolution Carmen Terzic
A day at the Human Cell Therapy Laboratory, Mayo Clinic Dennis Gastineau
March 27, 2011 Congress on Steroid Research Molecular basis of de novo and acquired aromatase inhibitor resistance S Cheng
March 1, 2011 "The Latest Advances in Liver Cancer Research: From Basic Science to Therapeutics" Session 2 | Epidemiology of HBV-related HCC W Ray Kim
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Promising New Drugs in Clinical Trials in Myeloma Keith Stewart
CON Keith Stewart
How I Treat Myelofibrosis If No Clinical Trial Is Available Ruben A Mesa
Multiple Myeloma Keith Stewart
Chronic Myeloid Leukemia | Myeloproliferative Neoplasms Ruben A Mesa
November 7, 2010 Ninth Annual International Conference on Frontiers in Cancer Prevention Research Molecular genetic research: Translating discovery into risk assessment and genetic testing Gloria M. Petersen
Introduction Gloria M. Petersen
Educational Sessions-2 : Trends in Epidemiology Research Gloria M. Petersen
Phase 0 trial of SR13668, an orally active AKT inhibitor Joel M. Reid
Stool DNA testing to screen colorectal and other aerodigestive cancers David A. Ahlquist
Concurrent Sessions - 13 : Colon Cancer Prevention Paul J. Limburg
September 30, 2010 Third AACR Conference on The Science of Cancer Health Disparities A Native American community perspective Judith S. Kaur,
Personalizing cancer therapy: Implications for health disparities Alex A Adjei
Plenary Session 8: Personalizing Cancer Prevention and Therapy Alex A Adjei
September 30, 2010 Third AACR Conference on the Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved A Native American community perspective Judith S. Kaur,
Personalizing cancer therapy: Implications for health disparities Alex A Adjei
Personalizing Cancer Prevention and Therapy Alex A Adjei
August 25, 2010 Molecular Diagnostics for Infectious Disease Clinical Diagnostics – Where Are We Going? Franklin R. Cockerill III
Sequencing-Based & Mass Spectroscopic Bacterial Identification in Clinical Microbiology Robin Patel
August 24, 2010 Enabling Point-of-Care Diagnostics - Moving Towards Rapid Diagnosis Clinical Diagnostics – Where Are We Going? Franklin R. Cockerill III
June 6, 2010 The Future of Molecular Epidemiology: New Tools, Biomarkers, and Opportunities Educational Session 3: Use of Biomarkers in Epidemiology: Study Design and Sources of Biases James R. Cerhan
Welcome and Keynote Session: Where is Molecular Epidemiology? Thomas A Sellers
Overview Gloria M. Petersen
Session 4: Biomarkers of Intervention and Clinical Response Gloria M. Petersen
Title to be announced Gloria M. Petersen
Panel Discussion The Future - Towards The Integration of Biomarkers into Epidemiology Gloria M. Petersen
Session 6: Challenges II – How Can Biomarker Studies Contribute to Cancer Prevention? Thomas A Sellers
June 4, 2010 From Chronic Inflammation to Cancer Chronic pancreatitis and pancreatic cancer Santhi Swaroop Vege
December 11, 2009 Santa Fe Gastrointestinal Cancer Conference Hepatocarcinogenesis of HCC Lewis R. Roberts
The Role of Liver Transplantation in Treating HCC Lewis R. Roberts
December 4, 2009 2009 Advances in Inflammatory Bowel Diseases Session II A: Advances in endoscopy in IBD | 1 Edward V. Loftus
Session I A: Plenary Session: State of the art in using biologics in IBD – I | 1 William Sandborn
Liver and pancreatic-biliary complications of IBD: Case studies | 1 Edward V. Loftus
Liver and pancreatic-biliary complications of IBD | 1 Edward V. Loftus
How to manage the non-compliant patient Sunanda V. Kane
Session VI A: Debates: Current controversies in IBD William J. Tremaine
Fistulizing Crohn's disease Edward V. Loftus
November 13, 2009 State of the Art: Multidisciplinary Approaches to Cholangiocarcinoma SESSION I: Understanding CCA Disease Process and Surveillance Keith D. Lindor
“Role of Endoscopic Ultrasound in Staging Cholangiocarcinoma” Keith D. Lindor
November 12, 2009 Sixth International Conference - Revitalizing Cancer Care: Comprehensive Interdisciplinary Programs and Whole Systems Research Critical Review/Summary of Level of Evidence/Research Direction Debra L. Barton
Session 1: Ayurveda Debra L. Barton
Introduction/Welcome Debra L. Barton
Lunch Satellite Session: Ginseng for Supportive Care in Cancer Treatment Debra L. Barton
October 1, 2009 6TH ANNUAL MEETING OF THE INTERNATIONAL SOCIETY OF GASTROINTESTINAL ONCOLOGY (ISGIO) Panel Discussion With Interactive Q/A Axel Grothey
Case Presentation 2: Metastatic But Potentially Curable Axel Grothey
Case Presentation 3: Stage Iva After Primary Surgery for Synchronous Liver Metastases- Previously Untreated Axel Grothey
September 21, 2009 Third Annual Exploring Next Generation Sequencing Genome Complexity Reduction and Next-Generation DNA Sequencing in a Clinical Diagnostics Environment Matthew Ferber
August 11, 2009 Inaugural Clinical Adoption of Next Generation Diagnostics Tamoxifen and CYP2D6: Using Pharmacogenetics to Individualize Breast Cancer Hormonal Therapy Matthew P . Goetz
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Strategy for Preclinical Cardiovascular Safety Evaluation for Biologicals Hugo Vargas
March 9, 2009 Drug Development Latin America PANEL DISCUSSION Interactive Panel with Managers from Clinical Trials Offices of National Regulatory Agencies Edith A Perez
December 11, 2008 SAN ANTONIO BREAST CANCER SYMPOSIUM Risk assessment and risk reduction strategies: Overview Lynn C Hartmann
November 10, 2008 The Burrill Personalized Medicine Meeting Personalized Medicine in the Clinic: Advances in Diagnosis and Treatment of Cancer Franklyn G. Prendergast
November 4, 2008 The Chemotherapy Foundation Symposium XXVI OR Chemotherapy Foundation Symposium, Innovative Cancer Therapy for Tomorrow AERODIGESTIVE CANCER PREVENTION Alex A Adjei
September 5, 2008 44th ASCO Annual Meeting General Session I: Risk, Screening, and Prevention Lynn C Hartmann
August 21, 2008 The Future of Cancer Diagnostics KEYNOTE PRESENTATION Franklyn G. Prendergast
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty Alex A Adjei
May 30, 2008 44th ASCO Annual Meeting Program Committee Michael G Haddock
Steering Commitee Leonard L Gunderson
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer Edith A Perez
developmental therapeutics-- Developmental Therapeutic Approaches to Triple-Negative Breast Cancer Edith A Perez
gastrointestinal (noncolorectal) cancer-- Multimodality Treatment of Bile Duct Tumors (M14) Steven R. Alberts
leukemia, myelodysplasia, and transplantation-- Myeloproliferative Disorders at the Cutting Edge Ayalew Tefferi
lymphoma and plasma cell disorders-- Initial Therapy for Multiple Myeloma: Considerations for an Integrated Risk- Adapted Approach S. Vincent Rajkumar
meet the professor sessions-- Multimodality Treatment of Bile Duct Tumors (M14) Steven R. Alberts
February 17, 2008 GRC - Glycolipid & Sphingolipid Biology Inhibition of caveolar endocytosis, microdomain formation and integrin signaling by a non-natural glycosphingolipid analog Ramandeep Singh Takhter
December 1, 2007 47TH American Socieity of Cell Biology Symposium II:Architecture of Signaling Systems Marks L Richard
Stochasticity and Cell Fate Marks L Richard
Advances in Bone Cell Molecular Biology: Epigenetic Control Jennifer Westendorf
Dynamics of Rafts, Stabilized Rafts, and Other Non-Raft Domains of Mark A McNiven
November 4, 2007 AACR Centennial Conference: Translational Cancer Medicine Concurrent Session 5: Advances in Cancer Therapeutics Alex A Adjei
September 7, 2007 The 2007 Breast Symposium General Session VI: HER2 Positive Breast Cancer 10:00 AM — 11:45 AM Edith A Perez
August 11, 2007 Lipid signaling Pathways in Cancer Oncogenic PKCiota signaling in human lung cancer Alan P Fields
July 28, 2007 Nutritional Immunology: Its Role in Health and Disease Endogenous activation and control of toll like receptors Jeffrey L Platt
July 21, 2007 Hematopoietic Malignancies Oncogene activation in the germinal center is the primary determinant of MM disease phenotype” Leif Bergsagel
A transgenic mouse model that faithfully reproduces the pathogenesis, biology and clinical features of multiple myeloma Marta Chesi
July 7, 2007 CHROMATIN AND TRANSCRIPTION Acetylation of lysine 56 of histone H3 catalyzed by Rtt109 and regulated by Asf1 Is required for replisome integrity Zhiguo Zhang
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.